(Q39264353)

10 September 2017

title

Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation (English)

1 reference

10 September 2017

Gyulai L

1

1 reference

10 September 2017

Bauer M

2

1 reference

10 September 2017

Garcia-Espana F

3

1 reference

10 September 2017

Hierholzer J

4

1 reference

10 September 2017

Baumgartner A

5

1 reference

10 September 2017

Berghöfer A

6

1 reference

10 September 2017

Whybrow PC

7

1 reference

10 September 2017

publication date

1 October 2001

1 reference

Journal of Affective Disorders

10 September 2017

published in

1 reference

10 September 2017

volume

66

1 reference

10 September 2017

issue

2-3

1 reference

10 September 2017

page(s)

185-191

1 reference

Bone mineral density in postmenopausal women treated with L-thyroxine

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Low thyrotropin levels are not associated with bone loss in older women: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Treatment of refractory depression with high-dose thyroxine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Epidemiology of osteoporosis and osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Long-term thyroxine treatment and bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

The effect of thyroid hormone on skeletal integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Bone mineral density in women with depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900306-2

7 January 2021

10.1016/S0165-0327(00)00306-2

Identifiers

DOI

1 reference

10 September 2017

1 reference